Guideline on quality, non-clinical and clinical requirements for investigational advanced therapy medicinal products in clinical trials

The guideline provides guidance on the structure and data requirements for a clinical trial application for exploratory and confirmatory trials with investigational advanced therapy medicinal products (ATMPs) and a perspective towards Marketing Authorisation Applications (MAA).